美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=FOSAMAX
符合检索条件的记录共8
1 页 当前第 1 页  返回检索页
1药品名称FOSAMAX
申请号020560产品号001
活性成分ALENDRONATE SODIUM市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/09/29申请机构MERCK AND CO INC
2药品名称FOSAMAX
申请号020560产品号002
活性成分ALENDRONATE SODIUM市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/09/29申请机构MERCK AND CO INC
3药品名称FOSAMAX
申请号020560产品号003
活性成分ALENDRONATE SODIUM市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1997/04/25申请机构MERCK AND CO INC
4药品名称FOSAMAX
申请号020560产品号004
活性成分ALENDRONATE SODIUM市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2000/10/20申请机构MERCK AND CO INC
5药品名称FOSAMAX
申请号020560产品号005
活性成分ALENDRONATE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 70MG BASE
治疗等效代码AB参比药物
批准日期2000/10/20申请机构MERCK AND CO INC
6药品名称FOSAMAX
申请号021575产品号001
活性成分ALENDRONATE SODIUM市场状态停止上市
剂型或给药途径SOLUTION;ORAL规格EQ 70MG BASE/75ML
治疗等效代码参比药物
批准日期2003/09/17申请机构MERCK AND CO INC
7药品名称FOSAMAX PLUS D
申请号021762产品号001
活性成分ALENDRONATE SODIUM; CHOLECALCIFEROL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 70MG BASE;2,800 IU
治疗等效代码参比药物
批准日期2005/04/07申请机构MERCK AND CO INC
8药品名称FOSAMAX PLUS D
申请号021762产品号002
活性成分ALENDRONATE SODIUM; CHOLECALCIFEROL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 70MG BASE;5,600 IU
治疗等效代码参比药物
批准日期2007/04/26申请机构MERCK AND CO INC